View : 869 Download: 0

Zabofloxacin 367mg For Five Days Versus Moxifloxacin 400mg For Seven Days In Patients With COPD Exacerbation: A Multicenter, Randomized, Double-Blind, Phase 3, Non-Inferiority Trial

Title
Zabofloxacin 367mg For Five Days Versus Moxifloxacin 400mg For Seven Days In Patients With COPD Exacerbation: A Multicenter, Randomized, Double-Blind, Phase 3, Non-Inferiority Trial
Authors
Kim, H.Lee, Y.Oh, Y. -M.Rhee, C. K.Kyung, S.Chang, J.Lee, W. -Y.Kim, J. S.
Ewha Authors
장중현
SCOPUS Author ID
장중현scopus
Issue Date
2015
Journal Title
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
ISSN
1073-449XJCR Link

1535-4970JCR Link
Citation
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE vol. 191
Publisher
AMER THORACIC SOC
Indexed
SCIE; SCOPUS WOS
Document Type
Meeting Abstract
Appears in Collections:
의과대학 > 의학과 > Journal papers
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

BROWSE